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electronic asthma action plans and electronic pre-school wheeze
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Joanna Ging5 and Hiran Selvadurai2,3
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Aim: To measure the long-term improvement in the documented provision of an asthma action plan (AAP) to children with asthma and wheeze
discharged from the Emergency Department following the introduction of the electronic AAP (eAAP) and to determine the need for an electronic
pre-school wheeze action plan in our population.
Methods: A retrospective case note review, from July 2014 to June 2015, of all patients over 12 months old discharged from the Emergency
Department or Emergency Medical Unit, with a discharge diagnosis of either asthma or wheeze. The primary outcome was the documentation of
an AAP, either recorded electronically as an eAAP or a report of an AAP as part of the patient medical record.
Results: Two thousand three hundred and forty-two patients were included in the study, 926 with asthma and 1416 with wheeze. The median
age was 3.3 years (interquartile range (IQR) 3.5, range 1–15.9 years). The median age of the children with asthma was 5.3 years (IQR 4.6) and of
the children with wheeze was 2.5 years (IQR 2.0).Overall, 1683 (71.9%) children had a documented AAP, with a signiﬁcant difference between
those with a discharge diagnosis of asthma (85.9%) compared with wheeze (62.9%), P < 0.001. These results justiﬁed the design of the electronic
pre-school wheeze action plan.
Conclusions: The integration of an eAAP into the Emergency Department has resulted in a sustained improvement in the documented provision
of an AAP to children with a discharge diagnosis of asthma. Children with a discharge diagnosis of wheeze are signiﬁcantly less likely to receive
an action plan.
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What is already known on this topic
1 The provision of an AAP to children is a key quality indicator.
2 The provision of an AAP to children reduces the rates of hospital
admissions, emergency presentations, school absences and use
of reliever medications.
3 The documented provision of an AAP to children discharged
after attending an Emergency Department may be suboptimal.
What this paper adds
1 The introduction of an electronic AAP into standard practice pro-
duces a sustained improvement in the documented provision of
the AAP on discharge from the Emergency Department.
2 Children discharged with a diagnosis of wheeze are signiﬁcantly
less likely to be given an AAP.
3 The use of a pre-school wheeze action plan may be a useful
resource for patients being discharged with a diagnosis of
wheeze, rather than asthma.
The provision of a personalised asthma action plan (AAP) to
patients with asthma is a key quality indicator and can improve
outcomes such as self-efﬁcacy, knowledge and conﬁdence for
people with asthma.1 In particular, patients with asthma who
have had a recent acute exacerbation, resulting in admission to
hospital, written personalised action plans may reduce readmis-
sion rates.1 AAPs for children are recommended internationally
by the Global Initiative for Asthma2 and in Australia by the
National Asthma Council (NAC)3 and have been shown to
reduce rates of hospital admissions, emergency presentations,
school absences and use of reliever medications.4
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The diagnosis of asthma in pre-school children can often be con-
troversial as the majority of patients who present with pre-school
wheeze do not develop chronic asthma.3,5,6 However, the provision
of an AAP to this group of patients is still widely
recommended.2,3,7–9 This is in line with a key concept of the new
Global Initiative for Asthma strategy: a road map to asthma control,
of ensuring good communication and partnership with the patient,
or carers in the case of pre-schoolers, considering health literacy,
personal goals and fears, and cultural issues.9 In particular, the pro-
vision of an AAP to children with pre-school wheeze may reduce
the prescription of oral steroids to this group, in line with the Tho-
racic Society of Australia and New Zealand position statement10 and
the NAC guidelines which state ‘Do not prescribe oral corticoster-
oids for children younger than 6 years unless acute wheezing is
severe enough to require hospitalisation’.3 The side effects of oral
steroids have been well described and risks are related to dosage
and duration of usage. Twenty percent of children having four or
more bursts per year demonstrate suboptimal adrenal response11
and multiple oral corticosteroid bursts over a period of years can
produce a dosage-dependent reduction in bone mineral accretion
and increased risk for osteopenia in boys, but not in girls.12
In 2008, The Children’s Hospital at Westmead demonstrated
an improvement in the documented provision of an AAP to chil-
dren discharged from the Emergency Department (ED) with a
discharge diagnosis of asthma, from 17.9 to 78.8% (P < 0.01) by
introducing an electronic AAP (eAAP) as standard of care.13 The
eAAP is prescribed via Power Chart at the physicians’ discretion
and integrated into the patient’s electronic medical record (eMR).
A paper copy is provided to the family, for home use, and can be
shown to the General Practitioner (GP) or school.
The aim of this study was to reaudit the documented provision
of an AAP to measure sustainability of the intervention, to meas-
ure the documented provision of an AAP to children with a dis-
charge diagnosis of wheeze. The second part of the paper was to
design and implement an electronic action plan for children with
pre-school wheeze (pre-school wheeze action plan (ePSWAP)).
Methods
Study design
A retrospective cross-sectional study of patients attending a large
paediatric tertiary level teaching hospital over 1 year from 1st July
2014 to 30th June 2015. The Children’s Hospital at Westmead
Emergency Department sees a total of more than 50 000 patients
each year. Ethical approval was granted by the Human Research
Ethics Committee of the Sydney Children’s Hospitals Network.
Participants
All patients over 12 months old who were discharged from the
ED or Emergency Medical Unit, a 24 h ward staffed by ED physi-
cians, with a discharge diagnosis of either asthma (ICD-10-J45.9)
or wheeze (ICD-10-R06.2).
Data sources and measurements
Case notes of patients attending the ED during the study dates
were extracted from the eMR (Health E-Care, MCare Systems,
Sydney, New South Wales, Australia).
The primary outcome was the documentation of an AAP,
either recorded electronically as an eAAP or a report of an AAP
as part of the patient notes.
Data for the primary outcome was combined from the eMR with
the eAAP database (Cerner Powerchart, Kansas City, MO, USA).
Where data matching was not possible electronically, patient
records were searched manually by the study investigators.
Where data was unable to be matched electronically and an
AAP was not identiﬁed by the ﬁrst investigator, a second investi-
gator reviewed the case notes to verify the absence of a
recorded AAP.
Statistics
The data were analysed using SPSS version 22.0 (IBM, Armonk,
NY, USA). Frequencies were summarised as percentages and 95%
conﬁdence intervals computed using a normal approximation.
The signiﬁcance of differences in frequencies between groups was
estimated using Pearson chi-square tests. Age had a right skewed
distribution and was therefore summarised using the median and
interquartile range (IQR). The difference in ages between groups
was examined using a Mann–Whitney U test for non-parametric
data. P-values <0.05 were considered statistically signiﬁcant.
Results
A total of 2351 patients were extracted from the databases. Nine
patients had incorrect discharge diagnoses, leaving 2342 patients
for inclusion in the study.
The median age was 3.3 years (IQR 3.5, range 1–15.9 years).
The median age of the children discharged with a diagnosis of
asthma was 5.3 years (IQR 4.6) and of the children discharged
with a diagnosis of wheeze was 2.5 years (IQR 2.0), with a differ-
ence of 2.8 years, P < 0.001.
A total of 1806 (77.1%) patients were admitted to the Emer-
gency Medical Unit, with the remainder being discharged directly
from ED.
Table 1 shows the frequencies of patients according to dis-
charge diagnosis, triage status and documented AAP. The triage
category reﬂects the severity of the presentation.
Design of pre-school wheeze action plan
Due to the signiﬁcant difference in the documented provision of
an AAP to those younger children discharged with a diagnosis of
wheeze an ePSWAP was developed. The investigators identiﬁed
several illustrative cases from the review where the use of a
PSWAP may have beneﬁted the patient (Table 2).
The ePSWAP was based on the four stages of the AAP cur-
rently advocated by the NAC: when well, when not well, if
symptoms get worse and danger signs.3 Sections were modiﬁed
to ensure the descriptives of each stage were applicable to the
pre-school age group and the section on preventers was
removed. It was decided that those patients with pre-school
wheeze requiring preventers should be on a conventional AAP.
The AAP was also modiﬁed to ensure the current best practice
around only using oral steroids for those exacerbations needing
hospital admissions was included.10 An example of an ePSWAP is
illustrated in Appendix I.
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Discussion
We have demonstrated a sustained improvement in the docu-
mented provision of an AAP to children over a 6-year period by
using an electronic AAP as standard of care. It has also shown a
signiﬁcant difference between those children discharged with a
diagnosis of asthma and those with a discharge diagnosis of
wheeze.
There are no ﬁrm criteria for categorising the discharge diag-
nosis as asthma or wheeze. The difference demonstrated probably
illustrates the problems in deﬁning asthma in the pre-school age
group described earlier. We are encouraged that 62.9% of
patients with wheeze did have an AAP, which is better than we
had predicted. The difference in the provision of an AAP may be
reﬂected in the doctors perception that children with asthma
should have an AAP, but those with wheeze do not need one.
We have illustrated several cases from where a PSWAP may have
helped parents care for their sick children more appropriately at
home, or seek help earlier (Table 2). These cases have been taken
from both the asthma and wheeze groups. The design and imple-
mentation of the PSWAP may lead to increased provision of a
plan for this group of children. Further studies are required to
determine if this is true and to determine if a PSWAP has the
same demonstrable beneﬁts seen in older children with AAPs.4
We would also like to encourage primary care physicians to con-
sider the provision of a PSWAP to the patients they see with
wheeze, who do not meet the criteria for an AAP.
We have demonstrated a sustained improvement in the pro-
vision of AAPs from 17.9% in 2007 to 71.9% overall, and
85.9% for those discharged with a diagnosis of asthma in
2014–2015. These results are consistent with the use of eAAPs
that have been described in other studies and, as well as
improved documented provision of an AAP, evaluations have
shown an association between eAAP receipt and signiﬁcant
reductions in paediatric asthma exacerbations, including 33%
lower odds of requiring oral steroids (P < 0.001), compared with
controls.14–16 In addition, the electronic sharing of the AAP has
the potential to increase efﬁciency and enhance effective com-
munication among health-care providers, families and schools.17
This may be a possible enhancement for the eAAP and ePSWAP
if they can be integrated with the Australian Patient Controlled
eHealth Record.18
Additional beneﬁts of the eAAP that have been anecdotally
reported include the ability to view the eAAP during subsequent
attendances and whilst providing telephone consultations to par-
ents. The eAAP used in this study can easily be modiﬁed as the
patient condition changes and provides a best practice, standar-
dised framework for the prescriber to use which is legible to the
consumer.
Table 1 Data frequencies and comparisons between patients discharged with a diagnosis of asthma or wheeze
Total sample Asthma Wheeze
P-value†n (%) % (95% CI) % (95% CI)
n 2342 926 1416
Triage category 1 3 (0.1%) — 0.2% (0, 0.4)
Triage category 2 220 (9.4%) 7.6% (5.9, 9.3) 10.6% (9.0, 12.2)
Triage category 3 1725 (73.7%) 70.3% (67.4, 73.2) 75.8% (73.6, 78.0)
Triage category 4 394 (16.8%) 22.1% (19.4, 24.8) 13.3% (11.5, 15.1)
Diagnosis Asthma 926 (39.5%)
Wheeze 1416 (60.5%)
Asthma action plan 1683 (71.9%) 85.9% (83.7, 88.1) 62.9% (60.4, 65.4) <0.001
†For the difference between the wheeze and asthma groups. CI, conﬁdence interval.
Table 2 Illustrative case descriptions of the need for a pre-school
wheeze action plan
One day of increasing cough and wheezy the morning of presentation
Parents gave three Ventolin puffs via spacer, though unsure how to
give it so came to ED
Previous episode of wheeze treated by GP with Ventolin, well in between
Family history of asthma
No documented previous AAP or AAP on discharge from ED
Three-year-old boy presented to ED at 17.00 with severe respiratory
distress
Runny nose and fever for last 24 h
Hard, noisy and fast breathing overnight – Mum tried one puff Ventolin
Previous episode of wheeze treated by GP
No documented previous AAP or AAP on discharge from ED
Three-year-old boy presented to ED at 16.30 with moderate
respiratory distress
Two-day history of cough and runny nose
Increased work of breathing since the morning
No reliever given at home. Went to GP who gave reliever and referred
to ED
History of multiple episodes of acute wheeze responsive to Ventolin
secondary to viral infections
Has eczema. Previous trial of 3-month course of Flixotide. Has eczema
No documented previous AAP or AAP on discharge from ED
Four-year-old presented to ED at 09.30 with severe respiratory distress
Runny nose for 2 days. Increasing cough, shortness of breath and
wheezing overnight
Parents giving three puffs every 30 min overnight at home
Unable to speak in sentences on arrival, respiratory rate 62 per minute
Two previous admissions to hospital of viral induced wheeze
No documented previous AAP or AAP on discharge from ED
AAP, asthma action plans; ED, Emergency Department; GP, General
Practitioner.
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One of the limitations of this study is the possibility that the
patients may have had an AAP prescribed by their paediatrician
or local GP and that this either was not asked or noted in the
medical record. This may explain some of the 14% of those with
a discharge diagnosis of asthma without an AAP. Other limita-
tions are consistent with any single institution retrospective chart
review. Our unique patient population, eMR and prescriber edu-
cation programme may not make our ﬁndings applicable in other
settings and our abstractors were not blinded to the study design
opening up the possibility of bias.
This study aimed to investigate the documented provision of
AAPs to children presenting to an tertiary ED. Further research is
required to measure patient outcomes related to the provision of
ePSWAPs such as frequency of GP visits, frequency of ED visits,
need for oral steroids, time off school, etc. which were not part of
this study design. Further research is also required to determine
which factors, such as doctor seniority, age of patient, patient loca-
tion and altering the design of the eMR to include auto triggering
of the ePSWAP, may inﬂuence the provision of an action plan.
Conclusions
The integration of an eAAP into the ED has resulted in a sustained
improvement in the documented provision of an AAP to children
with a discharge diagnosis of asthma. Children with a discharge
diagnosis of wheeze are signiﬁcantly less likely to receive an
Action Plan. The use of an ePSWAP may meet this need.
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Appendix I
Increasing difficulty breathing
Playing less than usual
No symptoms
AMO / GP: ……………………………….................. MRN: ……………………………………………………
HOSPITAL/PRACTICE: …………………………………… NAME: ……………………………………………………
DATE: ………………………………………………………….. DOB: ……………………………………………………
PRE-SCHOOL WHEEZE ACTION PLAN
No treatment required
Prednisolone (oral steroid) is not required for pre-school wheeze unless your 
child is admitted to hospital
Use a reliever to try and help them breathe
Consider a review by your General Practitioner
Use 2-4 puffs of …………………… with a spacer and face mask 3-4 times a day
Use 6 puffs of …………………… with a spacer and face mask every 3 hours
Take your child to your General Practitioner or local Emergency Department
Call an Ambulance. Say your child is having a severe wheeze attack
Use 4 separate puffs of …………………… with a spacer 
(and face mask if you have one) every 4 minutes until the 
ambulance arrives
Name and signature of prescriber:………………………………………………….
Adapted from the National Asthma Council Asthma Action Plan by The Children’s Hospital at Westmead 2015
Increasing cough or wheeze
Breathing harder or faster
Breathing Emergency
Breathing is so difficult that they are having trouble walking , talking, eating  or playing  
Child is drowsy or less alert than usual. Lips may be blue
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